Public Health Interventions Cost Effectiveness Database (PHICED)

Introduction

The Public Health Interventions Cost Effectiveness Database (PHICED) is a database of bibliographic records related to public health areas. It includes cost-effectiveness studies, NICE guidance and decision tools relating to alcohol, obesity, physical activity and tobacco. It is aimed at professionals who provide or commission public health interventions.

The development of this tool was funded by Health England and forms part of the National Library for Public Health.

Further information

Contact details

Please contact Sue Baughan if you have any feedback or comments about PHICED.

Search

Please note that the search filters operate automatically as they are chosen;-

       
 Public Health  AreaThe public health areas currently included on the website are; alcohol, obesity, physical activity and tobacco.    
  Limited By    
   CountryThis allows the user to specify the country/region where the study was conducted  
   Patient GroupThis allows the user to specify studies relating to a particular set of individuals with given characteristics.    
   InterventionThis allows the user to specify whether the study evaluates primary prevention or secondary prevention.    
      Searching Tips  
     

Results

Now showing 5 per page. On this page 16 to 20

Showing all records

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 

Intervention  Reference  PH Area  Patient Group  Country 
Primary
prevention 
Heitjan DF, Asch DA, Ray R, Rukstalis M, Patterson F, Lerman C. Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment. Pharmacogenomics Journal 2008; 8(6): 391-399 
Tobacco  Adults USA 
Primary
prevention 
Hampp C, Hartzema A G, Kauf T L. Cost-utility analysis of rimonabant in the treatment of obesity. Value in Health 2008; 11(3): 389-399 
Obesity  Adults USA 
Primary
prevention 
Galani C, Al M, Schneider H, Rutten F F. Uncertainty in decision-making: value of additional information in the cost-effectiveness of lifestyle intervention in overweight and obese people. Value in Health 2008; 11(3): 424-434 
Obesity,
Physical activity 
Adults Europe (not UK) 
Primary
prevention 
Bolin K, Mork A C, Willers S, Lindgren B. Varenicline as compared to bupropion in smoking-cessation therapy: cost-utility results for Sweden 2003. Respiratory Medicine 2008; 102(5): 699-710 
Tobacco  Adults Europe (not UK) 
Primary
prevention 
Bemelmans W, van Baal P, Wendel-Vos W, Schuit J, Feskens E, Ament A, Hoogenveen R. The costs, effects and cost-effectiveness of counteracting overweight on a population level: a scientific base for policy targets for the Dutch national plan for action. Preventive Medicine 2008; 46: 127-132 scientific base for policy targets for the dutch national plan for action. Preventive Medicine, 46, 127-132. 
Obesity  Adults Europe (not UK) 
Show    per page

Updated September 2011, based on searches undertaken on 24th August 2011